ArticleRisk management and healthcare policy2022

Cost-Effectiveness Analysis of Gefitinib Alone and Combined with Chemotherapy as First-Line Treatment for Patients with Advanced Non-Small-Cell Lung Cancer.

Yao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.